๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Assessment of Executive Function in Clinical Trials

โœ Scribed by Ylikoski, Raija; Hnninen, Tuomo

Book ID
118267969
Publisher
Cambridge University Press
Year
2003
Tongue
English
Weight
376 KB
Volume
15
Category
Article
ISSN
1041-6102

No coin nor oath required. For personal study only.

โœฆ Synopsis

Cerebrovascular disease and stroke are related to high risk of cognitive impairment. One of the main neuropsychological features in vascular cognitive impairment and vascular dementia is executive dysfunction. Definition of the essential subcomponents and concepts of executive function is important before determining the methodology in clinical trials. The scientific research and new methods on this topic are rapidly growing. We present some most commonly used neuropsychological tests and discuss the methodological aspects in light of clinical trials.

๐Ÿ“œ SIMILAR VOLUMES

Assessing cognitive function in clinical
Assessing cognitive function in clinical trials of schizophrenia
โœ Jennifer H. Barnett; Trevor W. Robbins; Verity C. Leeson; Barbara J. Sahakian; E ๐Ÿ“‚ Article ๐Ÿ“… 2010 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 435 KB

Cognitive dysfunction in schizophrenia is an important target for novel therapies. Effectively measuring the cognitive effects of compounds in clinical trials of schizophrenia could be a major barrier to drug development. The Measurement and Treatment Research to Improve Cognition in Schizophrenia (